News and Events | Precision Biologics

01DecDecember 1, 2020

Dr. Philip M. Arlen gives scientific presentation at World Vaccine & Immunotherapy Congress West Coast 2020, December 1 – 3, 2020

Dr. Philip M. Arlen gives scientific presentation at World Vaccine & Immunotherapy Congress West...

03NovNovember 3, 2020

Dr. Philip M. Arlen gives scientific presentation in 5th Annual Neoantigen Based Therapies Summit,...

06OctOctober 6, 2020

Dr. Philip M Arlen, MD, President and CEO is Presenting the Following Talk at...

25AugAugust 25, 2020

NIH Intramural Research Program (IRP) highlights Precision Biologics NEO-201 monoclonal antibody. READ FULL ARTICLE

15JulJuly 15, 2020

Precision Biologics in conjunction with our research collaborators at the National Cancer Institute (NCI)...

22JunJune 22, 2020

Precision Biologics along with our collaborators at the National Cancer Institute present research data...

30AprApril 30, 2020

Precision Biologics announces that the results of the Phase II Clinical Trial using its...

01MarMarch 1, 2020

Dr Massimo Fantini, Senior Scientist is Presenting the following Talk entitled: "Mechanisms of action...

25FebFebruary 25, 2020

Ariel Cahill Hollinshead Hyun, PhD, a pioneering cancer researcher whose work contributed to the...

07FebFebruary 7, 2020

NEO-201 is an IgG1 mAb targeting variants of CEACAM5/6 that demonstrates tumor sensitivity and...